NCT05920707 is a NA clinical trial of Intranasal Oxytocin in Healthy, sponsored by University of Electronic Science and Technology of China.

Who is sponsoring NCT05920707?

NCT05920707 is sponsored by University of Electronic Science and Technology of China.

What drugs are being tested in NCT05920707?

Interventions in NCT05920707: Intranasal Oxytocin, Intranasal Arginine Vasopressin, Intranasal placebo.

Is NCT05920707 still recruiting?

NCT05920707 is currently status unknown. Last updated 28 June 2023.

Last reviewed 2023-06-28 · How we verify

NCT05920707

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Common and Differentiated Representations Between Social Exclusion and Social Separation

Status unknown NA Last updated 28 June 2023

What this trial tests

NA trial testing Intranasal Oxytocin in Healthy in 120 participants. Status unknown.

Timeline

20 April 2023

Primary endpoint
20 September 2023

1 October 2023

Quick facts

Lead sponsor	University of Electronic Science and Technology of China
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	basic science
Enrollment	120
Start date	20 April 2023
Primary completion	20 September 2023
Estimated completion	1 October 2023
Sites	1 location across China

Drugs / interventions tested

Intranasal Oxytocin — full drug profile →
Intranasal Arginine Vasopressin — full drug profile →
Intranasal placebo — full drug profile →

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

University of Electronic Science and Technology of China

Who can join

Adults 18 to 30, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Explore the shared or separated neural mechanisms of social exclusion and social segregation and compare differential effects of AVP and OXT on these social interaction function.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Oxytocin and vasopressin enhance social pain empathy via common and distinct of neural expressions, genetic pathways, and networks.
Zhang X, Liu Q, Liu C, Wang Z, et al · · 2025 · cited 1× · PMID 41004228 · DOI 10.1073/pnas.2520651122

Verify or expand the search:

Other trials of Intranasal Oxytocin

Trials testing the same drug.

NCT05432089 — The Effects of Oxytocin Administration to Patients and Therapists on Physiological Synchronization · Phase 2 · recruiting
NCT05532501 — The Effects of Intranasal and Oral Administration of Oxytocin on Responses to Emotional Scenes · NA · unknown
NCT03593473 — Inhaled Oxytocin and HPA Axis Reactivity · Phase 2 · completed
NCT02985749 — A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder · Phase 3 · completed
NCT02127073 — Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer · Phase 2 · terminated

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other University of Electronic Science and Technology of China trials

Trials by the same sponsor.

NCT07416370 — Neurofeedback Training of Anterior Insula Activity Based on Unidimensional vs. Multidimensional Interoceptive Regulation · NA · enrolling by invitation
NCT07389486 — Continuous vs. Intermittent Rt-fMRI Neurofeedback Training of the Anterior Insula · NA · recruiting
NCT07425938 — Oxytocin's Effects on Emotional Processing and Its Acting Routes · NA · recruiting
NCT07364084 — Real-time Neurofeedback Training of the Medial Prefrontal Cortex Based on Imagined Social Support · NA · recruiting
NCT07367672 — The Power of Belief: Expectation-driven and Placebo Modulation of Empathic Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05920707 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Electronic Science and Technology of China
Last refreshed: 28 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05920707.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing